Series D funding round for Tarveda Therapeutics raising $30M in February 2017
Series D funding round for Tarveda Therapeutics raising $30M in February 2017
| Investor | Firm Type | Partner |
|---|
Versant VenturesLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 6 funding rounds. Current round is highlighted.
Total Raised
$129M
Top Valuation
-
Tarveda Therapeutics raised $30M in a Series D round.
The round was announced on 02/01/17.
The round was led by guido magni.